Global Health Ltd (Medanta) Share Price & Stock Analysis

Global Health Ltd (Medanta) (NSE: MEDANTA, BSE: 543654) is a Gurugram, Haryana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹38,422 Cr, it ranks #243 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 46 in Hospitals and Healthcare Centers. At ₹1,453.00 (as of 16 Nov 2026), the share price is 5.9% below its 52-week high of ₹1,544.00 and 52.0% above its 52-week low of ₹956.00. The share price is up 16.2% over one year and up 3.1% over three months.

Key Metrics

Current Price₹1,453.00
Market Cap₹38,422 Cr
NSE SymbolMEDANTA
BSE Code543654
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Facilities > Hospitals and Healthcare Centers
P/E Ratio69.7
Return on Equity15.03%
Return on Assets8.22%
52-Week Range₹956.00 – ₹1,544.00
1-Year Price Change+16.2%
3-Month Price Change+3.1%
Beta (1Y)0.17
Dividend Yield0.03%
HeadquartersGurugram, Haryana
Websitewww.medanta.org

Latest Quarterly Results — Q2 FY27

Revenue₹1,469 Cr
Net Profit₹219 Cr
Net Margin14.9%
EPS (Basic)₹8.21
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Global Health Ltd (Medanta) Quarterly Revenue and Profit Trend

Global Health Ltd (Medanta) reported revenue of ₹1,469 Cr in Q2 FY27, up 33.6% from ₹1,099 Cr in Q2 FY26 and up 12.7% from ₹1,304 Cr in Q1 FY27. It posted a net profit of ₹219 Cr for the quarter, against a net profit of ₹158 Cr in Q2 FY26 (up 38.3%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹931 Cr (Q4 FY25) to ₹1,469 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹1,469 Cr₹219 Cr14.9%
Q1 FY27₹1,304 Cr₹157 Cr12.1%
Q4 FY26₹1,159 Cr₹142 Cr12.2%
Q3 FY26₹1,121 Cr₹95 Cr8.5%
Q2 FY26₹1,099 Cr₹158 Cr14.4%
Q1 FY26₹1,031 Cr₹159 Cr15.4%
Q4 FY25₹931 Cr₹101 Cr10.9%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 33.00% of Global Health Ltd (Medanta)'s shares as of Sept 2026, against 33.01% in Sept 2025 (−0.01 percentage points). Delivery averaged 54.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Global Health Ltd (Medanta)

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and ot

Products and Services

1. The Healthcare Services-This segment offers healthcare services. 2. 0-0 3. 0-0 4. 0-0

Business Segments

1. The Healthcare Services-100%

Global Health Ltd (Medanta) vs Peers — Hospitals and Healthcare Centers

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Apollo Hospitals Enterprise Limited₹1,23,712 Cr6321.50%₹7,615 Cr+11.6%
Max Healthcare Institute Ltd₹91,978 Cr63.914.33%₹2,569 Cr-16.6%
Manipal Health Enterprises Ltd₹89,110 Cr88.4—₹3,399 Cr—
Aster Dm Healthcare Limited (Asterdm)₹63,041 Cr97.610.07%₹2,829 Cr+4.3%
Fortis Healthcare Ltd.₹58,283 Cr55.111.01%₹2,735 Cr-25.1%
Global Health Ltd (Medanta)₹38,422 Cr69.715.03%₹1,469 Cr+16.2%
Narayana Hrudayalaya Limited₹37,907 Cr46.219.85%₹2,844 Cr+2.8%
Krishna Institute Of Medical Science (KIMS)₹29,056 Cr120.69.72%₹1,344 Cr+0.2%
Dr. Agarwal's Health Care Limited₹17,568 Cr131.98.31%₹655 Cr+9.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Global Health Ltd (Medanta)?

Global Health Ltd (Medanta) is trading at ₹1,453.00, with a market capitalisation of ₹38,422 Cr.

Which sector does Global Health Ltd (Medanta) belong to?

Global Health Ltd (Medanta) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).

What are the key financial ratios of Global Health Ltd (Medanta)?

Global Health Ltd (Medanta) has a P/E of 69.7 and a return on equity of 15.03%.

What is the stock symbol of Global Health Ltd (Medanta)?

Global Health Ltd (Medanta) is listed on the NSE under the symbol MEDANTA and on the BSE under the scrip code 543654.

How has Global Health Ltd (Medanta)'s share price moved over the past year?

Global Health Ltd (Medanta)'s share price is up 16.2% over one year and up 3.1% over three months. Its 52-week range is ₹956.00 to ₹1,544.00.

What were Global Health Ltd (Medanta)'s latest quarterly results?

In Q2 FY27, Global Health Ltd (Medanta) reported revenue of ₹1,469 Cr and net profit of ₹219 Cr, with basic EPS of ₹8.21 (consolidated, parsed from the company's exchange filing).

How have Global Health Ltd (Medanta)'s revenue and profit changed over the past year?

Global Health Ltd (Medanta) reported revenue of ₹1,469 Cr in Q2 FY27, up 33.6% from ₹1,099 Cr in Q2 FY26 and up 12.7% from ₹1,304 Cr in Q1 FY27.

What is the promoter holding in Global Health Ltd (Medanta)?

Promoters held 33.00% of Global Health Ltd (Medanta)'s shares as of Sept 2026, against 33.01% in Sept 2025 (−0.01 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.